Yoshiaki Ohtsu

23 papers receiving 460 citations

Peers

Yoshiaki Ohtsu
Comparison fields: 5 of 76
  • Pulmonary and Respiratory Medicine 184
  • Molecular Biology 99
  • Oncology 87
  • Endocrinology, Diabetes and Metabolism 82
  • Radiology, Nuclear Medicine and Imaging 74
Replace Hans Stieltjes with:
Hans Stieltjes Belgium
Elena Guerini Switzerland
Daria Stypinski United States
Enaksha Wickremsinhe United States
Mindy Magee United States
Yali Liang United States
Donald M. Gibson United States
Madelé van Dyk Australia
Lisa J. Christopher United States
Matthew Hruska United States
Yoshiaki Ohtsu relative to Hans Stieltjes Belgium Hans Stieltjes's profile →
Citations per field
00.5×1.7×
Hans Stieltjes · 1×
Citations per year

Countries citing papers authored by Yoshiaki Ohtsu

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Ohtsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Ohtsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Ohtsu more than expected).

Fields of papers citing papers by Yoshiaki Ohtsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Ohtsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Ohtsu. The network helps show where Yoshiaki Ohtsu may publish in the future.

Co-authorship network of co-authors of Yoshiaki Ohtsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Ohtsu. A scholar is included among the top collaborators of Yoshiaki Ohtsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Ohtsu. Yoshiaki Ohtsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 19
3 3
4 4
5 20
6 9
7 4
8 7
9 9
10 109
11 2
12 120
13 9
14 52
15 2
16 1
17 9
18 24
19 24
20 5

About Yoshiaki Ohtsu

Yoshiaki Ohtsu is a scholar working on Pharmacology, Immunology and Statistics and Probability, having authored 26 papers that have together received 477 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Pharmacology (72 citations), Pulmonary and Respiratory Medicine (184 citations) and Endocrinology, Diabetes and Metabolism (82 citations). Yoshiaki Ohtsu has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Jacqueline A. Gibbons, Michiel S. de Vries, Joyce Mordenti, Jan‐Stefan van der Walt, Walter Krauwinkel, Taoufik Ouatas, Roelof Mol, Nico van de Merbel, Clark Williard and Kelly Dong. Their work appears in journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Biochimica et Biophysica Acta (BBA) - Biomembranes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026